Anila D’Mello is an assistant professor and Jon Heighten Scholar in Autism Research in the Department of Psychiatry and O’Donnell Brain Institute at the University of Texas Southwestern in Dallas.
Anila D’Mello
Assistant professor
University of Texas Southwestern
From this contributor
How scientists can counteract their unwitting contributions to autism’s sex bias
Common diagnostic and research practices may be adding to autism’s sex bias, but there are some simple steps scientists can take to counteract it.
How scientists can counteract their unwitting contributions to autism’s sex bias
By
Anila D’Mello
20 December 2022 | 7 min read
Explore more from The Transmitter
Genetic profiles separate early, late autism diagnoses
Age at diagnosis reflects underlying differences in common genetic variants and developmental trajectories among people with autism.
Genetic profiles separate early, late autism diagnoses
Age at diagnosis reflects underlying differences in common genetic variants and developmental trajectories among people with autism.
By
Natalia Mesa
27 November 2025 | 5 min read
To persist, memories surf molecular waves from thalamus to cortex
During the later stages of learning, the mouse brain progressively activates transcriptional regulators that drive memory consolidation.
To persist, memories surf molecular waves from thalamus to cortex
During the later stages of learning, the mouse brain progressively activates transcriptional regulators that drive memory consolidation.
By
Claudia López Lloreda
26 November 2025 | 4 min read
Sex hormone boosts female rats’ sensitivity to unexpected rewards
During the high-estradiol stages of their estrus cycle, female rats learn faster than they do during other stages—and than male rats overall—thanks to a boost in their dopaminergic response to reward, a new study suggests.
Sex hormone boosts female rats’ sensitivity to unexpected rewards
During the high-estradiol stages of their estrus cycle, female rats learn faster than they do during other stages—and than male rats overall—thanks to a boost in their dopaminergic response to reward, a new study suggests.
By
Angie Voyles Askham
26 November 2025 | 5 min read